Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

被引：6

作者：

Niparuck, Pimjai ^{[1
]}

Kanoksil, Wasana

Chuncharunee, Suporn ^{[1
]}

Boonsakan, Paisarn

Ungkanont, Artit ^{[1
]}

Angchaisuksiri, Pantep ^{[1
]}

Karntisaviwat, Kanlaya ^{[2
]}

Apilugsanachit, Axara ^{[2
]}

Rerkamnuatchoke, Budsaba ^{[2
]}

Jootar, Saengsuree ^{[1
]}

Nitiyanant, Prawat

Atichartakarn, Vichai ^{[1
]}

机构：

[1] Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand

[2] Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand

来源：

LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 11期

关键词：

RITUXIMAB;

D O I：

10.3109/10428194.2010.505675

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2120 / 2125

页数：6

共 8 条

[1] Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712) [J].

Byrd, JC ;

Peterson, BL ;

Morrison, VA ;

Park, K ;

Jacobson, R ;

Hoke, E ;

Vardiman, JW ;

Rai, K ;

Schiffer, CA ;

Larson, RA .

BLOOD, 2003, 101 (01) :6-14

[2] Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone [J].

Di Gaetano, N ;

Xiao, Y ;

Erba, E ;

Bassan, R ;

Rambaldi, A ;

Golay, J ;

Introna, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) :800-809

[3] Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha [J].

McLaughlin, P ;

Estey, E ;

Glassman, A ;

Romaguera, J ;

Samaniego, F ;

Ayala, A ;

Hayes, K ;

Maddox, AM ;

Preti, HA ;

Hagemeister, FB .

BLOOD, 2005, 105 (12) :4573-4575

[4] Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma [J].

Misgeld, E ;

Germing, U ;

Aul, C ;

Gattermann, N .

LEUKEMIA RESEARCH, 2001, 25 (01) :95-98

Morrison, VA ;

Rai, KR ;

Peterson, BL ;

Kolitz, JE ;

Elias, L ;

Appelbaum, FR ;

Hines, JD ;

Shepherd, L ;

Larson, RA ;

Schiffer, CA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3878-3884

[6]

TAM SC, 2006, HEMATOLOGICA, V91, P1546

[7] Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia [J].

Wierda, W ;

O'Brien, S ;

Wen, S ;

Faderl, S ;

Garcia-Manero, G ;

Thomas, D ;

Do, KA ;

Cortes, J ;

Koller, C ;

Beran, M ;

Ferrajoli, A ;

Giles, F ;

Lerner, S ;

Albitar, M ;

Kantarjian, H ;

Keating, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4070-4078

[8]

Yamauchi T, 2001, CLIN CANCER RES, V7, P3580

← 1 →